Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

US Patent 12097242 · Granted Sep 24, 2024

Estimated economic value: $220,648,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glypican-3-binding fibronectin based scaffold molecules2025
Ipilimumab variants with enhanced specificity for binding at low pH2025
Nectin-4 binding miniproteins, conjugates and uses thereof2025
Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containin2025
Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containin2025
PD-L1 binding polypeptides for imaging2025
PD-L1 binding polypeptides for imaging2025
Apelin receptor agonists and methods of use2024
Apelin receptor agonists and methods of use2024
Methods of treating kidney failure, and/or improving or stablizing renal functio2024
Methods of treating kidney failure, and/or improving or stablizing renal functio2024
Methods of treating kidney failure, and/or improving or stablizing renal functio2024